AGP Picks
View all

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

Press releases published on November 19, 2026

J-Star Holding Expands Mitsubishi Chemical Partnership to Advance U.S. UAV Manufacturing and Domestic Carbon Fiber Supply Chain
Enable Injections and ARespo Biopharma Announce Strategic Partnership
Marker Therapeutics Awarded $16.2 Million CPRIT Grant to Advance MT-601 in Phase 2 APOLLO Study
ANI Pharmaceuticals to Present at Upcoming December Investor Conference
CDT Notes Sarborg’s Sale of Cryptocurrency Trading Agent
EBI Reaches Key Milestone with First Patient Enrolled in Phase III EasyBoost Trial of EA-230, a Potential First-in-Class Medicine to Accelerate Recovery After Cardiac Surgery
Zymeworks Announces Participation in Upcoming Investor Conferences
DeepHealth to Present Recent Clinical Evidence Demonstrating the Breadth and Impact of Its AI Portfolio at RSNA 2026
Codexis to Participate in Piper Sandler 38th Annual Healthcare Conference
A Race Against Blindness Brings Back “Miles, Magic & Mochas” Fundraiser for the Holiday Season
HUTCHMED Announces China NMPA Approval of SYVIK® (sovleplenib) for the Treatment of Primary Immune Thrombocytopenia and Warm Antibody Autoimmune Hemolytic Anemia
Arcera Life Sciences and Innogen Pharmaceuticals Sign Exclusive Licensing Agreement to Expand Access to Cardiometabolic Care Across International Markets
Asgard Therapeutics awarded €2.5m EIC Accelerator grant to advance lead program AT-108 toward the clinic
DISCO Pharmaceuticals Announces Strategic Collaboration with AbbVie to Advance Next-Generation AND-Gated Bispecific Therapeutics for Solid Tumors
Scancell Provides Corporate and Clinical Update
AVA6207 Overcomes Topoisomerase I Inhibitor Resistance In Vitro and In Vivo with Robust and Tumor-Selective Release of Dual Exatecan and ATR Inhibitor Payloads
Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
Communiqué de presse : VaxRabeo, le vaccin contre la rage de nouvelle génération de Sanofi, approuvé dans l’UE pour tous les âges
Fangzhou and Baiyunshan Pharmaceutical Launch AI-Powered Chronic Disease Management Initiative
SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public Offering

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Washington

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.